MHB3™ - THE NEXT GENERATION
IN SYSTEMIC JOINT CARE
Pre-clinical and clinical research shows that MHB3™ is responsible for maintaining – and even improving – the quality of cartilage in joints. >> Read more

ABOUT COGENT SOLUTIONS GROUP
Founded in 2005, Cogent Solutions Group, LLC (CSG) identifies, develops, and delivers innovative and effective biomacromolecules based on fundamental scientific and clinical research the company sponsors at leading institutions throughout North America. We explore the interactions of modified macromolecules with biological systems and their environments - going beyond the amelioration of symptoms to actually modify disease. Our greatest strength is our team of dedicated professionals with core competencies in biochemistry, molecular biology, nutrition, and human and veterinary medicine. We believe in the power of science, purpose, and people, concentrating our energies and using our experience to bring important products to the marketplace. We are proud of our success and excited about our potential.

OUR MISSION
Deliver the highest possible level of customer satisfaction with our products and service interactions in a responsible and ethical manner.